Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report) shares were up 3.5% during mid-day trading on Wednesday . The stock traded as high as $0.7849 and last traded at $0.7419. Approximately 5,530,204 shares traded hands during mid-day trading, an increase of 24,342% from the average daily volume of 22,626 shares. The stock had previously closed at $0.7167.
Bellevue Life Sciences Acquisition Stock Performance
The firm’s 50 day simple moving average is $0.63 and its 200 day simple moving average is $0.72.
Bellevue Life Sciences Acquisition Company Profile
Bellevue Life Sciences Acquisition Corp. (NASDAQ: BLAC) is a special purpose acquisition company organized as a Delaware corporation. The company completed its initial public offering in 2021, raising gross proceeds to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more life sciences businesses.
BLAC’s principal activity is to identify and complete a business combination with a target operating company in the life sciences sector.
Read More
- Five stocks we like better than Bellevue Life Sciences Acquisition
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
